To provide guidance for the diagnosis and treatment of rare diseases, the "Chinese Expert Consensus on the Diagnosis and Treatment of Gitelman Syndrome (2021 Edition)" is released
Time of Update: 2022-01-10
The new clinical phenotypes, disease types, modified functional tests, biomarkers and management experience of special populations of Gitelman syndrome in Chinese population have been reported in domestic and foreign journals .
Polyethylene Glycol (PEG)-Mediated Transformation in Filamentous Fungal Pathogens
Time of Update: 2021-03-10
The genetic transformation of many fungal species is well established and can be carried out by utilizing different transformation methods including electroporation, Agrobacterium, biolistics, or polyethylene glycol (PEG)-mediated transformation.
Here, we describe a PEG-based protocol developed for genetic transformation ofStagonospora nodorum , a fungal pathogen of wheat.
Ebiomedicine: a new diagnostic technique for multiple sclerosis
Time of Update: 2021-02-27
Commenting on the importance of this work, Professor Pentti Tienari, Professor of Neuroscience at the University of Helsinki and co-author of the study, said: "THE treatment of MS is most effective and starts early, but very few biomarkers can be used to identify high-risk groups after the onset of optic neuritis.
The "methylation gene map" of cotton's egenesitical genes was first mapped by Chinese and American scientists
Time of Update: 2020-09-01
DNA methylation is an important ephegenic modification process, and the new map information can provide ephemgenic genetic changes in cotton over a million years of evolution, helping researchers select new varieties with certain new characteristics, increasing cotton yields, and improving their drought, heat, or insect resistance.
PfSET1, the essential gene for the growth of Plasmodium falciparum, is involved in regulation
Time of Update: 2020-08-06
Jiang Lubin's research team successfully built a new gene editing tool based on epigenetic modification in Plasmodium falciparum using the CRISPR/dCas9 system.